160 related articles for article (PubMed ID: 26081024)
41. YD-3, a novel inhibitor of protease-induced platelet activation.
Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
[TBL] [Abstract][Full Text] [Related]
42. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets.
Sheu JR; Lee CR; Lin CH; Hsiao G; Ko WC; Chen YC; Yen MH
Thromb Haemost; 2000 May; 83(5):777-84. PubMed ID: 10823277
[TBL] [Abstract][Full Text] [Related]
43. [The antiaggregant action of 2-morpholino-5-(thienyl-2)-6-H-1,3,4-thiadiazine in in vitro and ex vivo experiments].
Logvinova IuS; Makarov VA; Chupakhin ON; Sidorova LP; Perova NM; Rusinov VL
Eksp Klin Farmakol; 2013; 76(2):13-6. PubMed ID: 23631277
[TBL] [Abstract][Full Text] [Related]
44. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
45. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
Chen R; Liang N
Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
[TBL] [Abstract][Full Text] [Related]
46. Effects of three trans isomers of eicosapentaenoic acid on rat platelet aggregation and arachidonic acid metabolism.
Loï C; Chardigny JM; Berdeaux O; Vatèle JM; Poullain D; Noël JP; Sébédio JL
Thromb Haemost; 1998 Oct; 80(4):656-61. PubMed ID: 9798987
[TBL] [Abstract][Full Text] [Related]
47. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
48. The effects of okadaic acid and calyculin A on thrombin induced platelet reaction.
Murata K; Sakon M; Kambayashi J; Yukawa M; Ariyoshi H; Shiba E; Kawasaki T; Kang J; Mori T
Biochem Int; 1992 Feb; 26(2):327-34. PubMed ID: 1313673
[TBL] [Abstract][Full Text] [Related]
49. Dehydroepiandrosterone-sulfate inhibits thrombin-induced platelet aggregation.
Bertoni A; Rastoldo A; Sarasso C; Di Vito C; Sampietro S; Nalin M; Bagarotti A; Sinigaglia F
Steroids; 2012 Feb; 77(3):260-8. PubMed ID: 22182832
[TBL] [Abstract][Full Text] [Related]
50. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA
Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154
[TBL] [Abstract][Full Text] [Related]
51. Effects of ascorbate fatty ester derivatives on erythrocyte membrane lipoperoxidation.
Spengler MI; Rasia M; Palma S; Allemandi D
Clin Hemorheol Microcirc; 2011; 47(3):163-8. PubMed ID: 21498895
[TBL] [Abstract][Full Text] [Related]
52. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.
Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH
Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810
[TBL] [Abstract][Full Text] [Related]
53. The effects of polyphenols in olive leaves on platelet function.
Singh I; Mok M; Christensen AM; Turner AH; Hawley JA
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):127-32. PubMed ID: 17346951
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and evaluation of platelet aggregation inhibitory activity of some 3-phenyl-pyrroloquinazolinones.
Ferlin MG; Borgo C; Deana R
Eur J Med Chem; 2012 Feb; 48():275-83. PubMed ID: 22236469
[TBL] [Abstract][Full Text] [Related]
55. Biosynthesis of Novel Ascorbic Acid Esters and Their Encapsulation in Lignin Nanoparticles as Carriers and Stabilizing Systems.
Capecchi E; Piccinino D; Nascimben C; Tomaino E; Ceccotti Vlas N; Gabellone S; Saladino R
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240391
[TBL] [Abstract][Full Text] [Related]
56. Imperanene, a novel phenolic compound with platelet aggregation inhibitory activity from Imperata cylindrica.
Matsunaga K; Shibuya M; Ohizumi Y
J Nat Prod; 1995 Jan; 58(1):138-9. PubMed ID: 7760071
[TBL] [Abstract][Full Text] [Related]
57. Drug nanoparticle formulation using ascorbic Acid derivatives.
Moribe K; Limwikrant W; Higashi K; Yamamoto K
J Drug Deliv; 2011; 2011():138929. PubMed ID: 21603195
[TBL] [Abstract][Full Text] [Related]
58. [BIOCHEMICAL STUDIES ON PHYSIOLOGICAL UTILIZABILITY OF L-ASCORBYL STEARINE ESTER].
MURATA H
Tokyo Jikeikai Ika Daigaku Zasshi; 1964 Jul; 22():237-62. PubMed ID: 14288523
[No Abstract] [Full Text] [Related]
59. Anticancer effects of 6-o-palmitoyl-ascorbate combined with a capacitive-resistive electric transfer hyperthermic apparatus as compared with ascorbate in relation to ascorbyl radical generation.
Kato S; Asada R; Kageyama K; Saitoh Y; Miwa N
Cytotechnology; 2011 Aug; 63(4):425-35. PubMed ID: 21667158
[TBL] [Abstract][Full Text] [Related]
60. Studies on the stability of ascorbic acid. V. Critical micelle concentration of ascorbyl monofatty acid esters.
Tukamoto T; Ozeki S; Tejima K; Adachi S
Chem Pharm Bull (Tokyo); 1971 Apr; 19(4):804-7. PubMed ID: 4996655
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
